HEADER HYDROLASE 13-SEP-02 1MQ0 TITLE CRYSTAL STRUCTURE OF HUMAN CYTIDINE DEAMINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTIDINE DEAMINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYTIDINE AMINOHYDROLASE; COMPND 5 EC: 3.5.4.5; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS HUMAN, ENZYME, CYTIDINE DEAMINASE, AMINE HYDROLASE, INHIBITOR, KEYWDS 2 DIAZEPINONE, LEUKEMIA, CHEMOTHERAPY, ANTICANCER, DRUG, PHI-PHI KEYWDS 3 INTERACTION, EDGE-TO-FACE INTERACTION, PROTEIN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.J.CHUNG,J.C.FROMME,G.L.VERDINE REVDAT 7 14-FEB-24 1MQ0 1 REMARK REVDAT 6 27-OCT-21 1MQ0 1 REMARK SEQADV LINK REVDAT 5 11-OCT-17 1MQ0 1 REMARK REVDAT 4 13-JUL-11 1MQ0 1 VERSN REVDAT 3 24-FEB-09 1MQ0 1 VERSN REVDAT 2 08-MAR-05 1MQ0 1 JRNL REVDAT 1 04-NOV-03 1MQ0 0 JRNL AUTH S.J.CHUNG,J.C.FROMME,G.L.VERDINE JRNL TITL STRUCTURE OF HUMAN CYTIDINE DEAMINASE BOUND TO A POTENT JRNL TITL 2 INHIBITOR JRNL REF J.MED.CHEM. V. 48 658 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 15689149 JRNL DOI 10.1021/JM0496279 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 210371.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 10555 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 520 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1646 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 83 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1922 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 19.15000 REMARK 3 B22 (A**2) : -7.11000 REMARK 3 B33 (A**2) : -12.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.51 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.600 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.240 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 51.75 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CDA_INHIBITOR.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA_REP.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : CDA_INHIBITOR.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MQ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-SEP-02. REMARK 100 THE DEPOSITION ID IS D_1000017085. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUL-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NICKEL FILTER REMARK 200 OPTICS : OSMIC BLUE REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11082 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 4.580 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.56 REMARK 200 R MERGE FOR SHELL (I) : 0.32600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1JTK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, 2-METHYL-2,4-PENTANE REMARK 280 -DIOL, CALCIUM CHLORIDE, SYNTHETIC INHIBITOR, PH 4.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 26.19900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.84000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.19900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.84000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A TETRAMER, AND THERE IS A DIMER IN REMARK 300 THE ASYMMETRIC UNIT. THE OTHER DIMER OF THE TETRAMER CAN BE REMARK 300 OBTAINED BY THE FOLLOWING SYMMETRY OPERATION: (-X, -Y,Z) DX=1 DY=3 REMARK 300 DZ=0 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -219.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 52.39800 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 167.04000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 HIS A 9 REMARK 465 MET A 10 REMARK 465 LYS A 11 REMARK 465 PRO A 12 REMARK 465 GLN A 143 REMARK 465 LYS A 144 REMARK 465 THR A 145 REMARK 465 GLN A 146 REMARK 465 GLY B 7 REMARK 465 SER B 8 REMARK 465 HIS B 9 REMARK 465 MET B 10 REMARK 465 LYS B 11 REMARK 465 PRO B 12 REMARK 465 GLN B 143 REMARK 465 LYS B 144 REMARK 465 THR B 145 REMARK 465 GLN B 146 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 13 CB CG CD OE1 OE2 REMARK 470 CYS A 14 CB SG REMARK 470 GLN A 17 CG CD OE1 NE2 REMARK 470 LEU A 19 CG CD1 CD2 REMARK 470 GLN A 45 CG CD OE1 NE2 REMARK 470 LYS A 51 CG CD CE NZ REMARK 470 ARG A 83 CB CG CD NE CZ NH1 NH2 REMARK 470 GLN A 92 CB CG CD OE1 NE2 REMARK 470 ASP A 93 CB CG OD1 OD2 REMARK 470 ASP A 94 CB CG OD1 OD2 REMARK 470 ILE A 125 CD1 REMARK 470 SER A 135 OG REMARK 470 LEU A 142 CG CD1 CD2 REMARK 470 GLU B 13 CB CG CD OE1 OE2 REMARK 470 CYS B 14 SG REMARK 470 GLN B 27 CG CD OE1 NE2 REMARK 470 SER B 28 OG REMARK 470 GLN B 45 CG CD OE1 NE2 REMARK 470 LYS B 73 CG CD CE NZ REMARK 470 ASP B 81 CG OD1 OD2 REMARK 470 ARG B 83 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 93 CB CG OD1 OD2 REMARK 470 ASN B 112 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN B 92 OE1 GLN B 92 2785 1.46 REMARK 500 OD2 ASP B 94 OD1 ASP B 141 2685 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 14 144.42 174.56 REMARK 500 ASP A 81 -87.45 -82.54 REMARK 500 PHE A 82 119.45 82.03 REMARK 500 ALA A 84 168.03 175.05 REMARK 500 ASP A 94 151.70 111.62 REMARK 500 TRP A 113 153.30 -48.29 REMARK 500 TYR B 60 -53.34 -27.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 147 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 65 SG REMARK 620 2 CYS A 99 SG 108.7 REMARK 620 3 CYS A 102 SG 109.8 115.7 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 147 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 65 SG REMARK 620 2 CYS B 99 SG 116.2 REMARK 620 3 CYS B 102 SG 99.4 129.4 REMARK 620 4 HOH B 151 O 108.7 100.7 100.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRD A 148 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRD B 149 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JTK RELATED DB: PDB REMARK 900 CYTIDINE DEAMINASE FROM B. SUBTILIS DBREF 1MQ0 A 11 146 UNP P32320 CDD_HUMAN 11 146 DBREF 1MQ0 B 11 146 UNP P32320 CDD_HUMAN 11 146 SEQADV 1MQ0 GLY A 7 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 SER A 8 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 HIS A 9 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 MET A 10 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 GLN A 27 UNP P32320 LYS 27 ENGINEERED MUTATION SEQADV 1MQ0 GLY B 7 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 SER B 8 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 HIS B 9 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 MET B 10 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 GLN B 27 UNP P32320 LYS 27 ENGINEERED MUTATION SEQRES 1 A 140 GLY SER HIS MET LYS PRO GLU CYS VAL GLN GLN LEU LEU SEQRES 2 A 140 VAL CYS SER GLN GLU ALA LYS GLN SER ALA TYR CYS PRO SEQRES 3 A 140 TYR SER HIS PHE PRO VAL GLY ALA ALA LEU LEU THR GLN SEQRES 4 A 140 GLU GLY ARG ILE PHE LYS GLY CYS ASN ILE GLU ASN ALA SEQRES 5 A 140 CYS TYR PRO LEU GLY ILE CYS ALA GLU ARG THR ALA ILE SEQRES 6 A 140 GLN LYS ALA VAL SER GLU GLY TYR LYS ASP PHE ARG ALA SEQRES 7 A 140 ILE ALA ILE ALA SER ASP MET GLN ASP ASP PHE ILE SER SEQRES 8 A 140 PRO CYS GLY ALA CYS ARG GLN VAL MET ARG GLU PHE GLY SEQRES 9 A 140 THR ASN TRP PRO VAL TYR MET THR LYS PRO ASP GLY THR SEQRES 10 A 140 TYR ILE VAL MET THR VAL GLN GLU LEU LEU PRO SER SER SEQRES 11 A 140 PHE GLY PRO GLU ASP LEU GLN LYS THR GLN SEQRES 1 B 140 GLY SER HIS MET LYS PRO GLU CYS VAL GLN GLN LEU LEU SEQRES 2 B 140 VAL CYS SER GLN GLU ALA LYS GLN SER ALA TYR CYS PRO SEQRES 3 B 140 TYR SER HIS PHE PRO VAL GLY ALA ALA LEU LEU THR GLN SEQRES 4 B 140 GLU GLY ARG ILE PHE LYS GLY CYS ASN ILE GLU ASN ALA SEQRES 5 B 140 CYS TYR PRO LEU GLY ILE CYS ALA GLU ARG THR ALA ILE SEQRES 6 B 140 GLN LYS ALA VAL SER GLU GLY TYR LYS ASP PHE ARG ALA SEQRES 7 B 140 ILE ALA ILE ALA SER ASP MET GLN ASP ASP PHE ILE SER SEQRES 8 B 140 PRO CYS GLY ALA CYS ARG GLN VAL MET ARG GLU PHE GLY SEQRES 9 B 140 THR ASN TRP PRO VAL TYR MET THR LYS PRO ASP GLY THR SEQRES 10 B 140 TYR ILE VAL MET THR VAL GLN GLU LEU LEU PRO SER SER SEQRES 11 B 140 PHE GLY PRO GLU ASP LEU GLN LYS THR GLN HET ZN A 147 1 HET BRD A 148 17 HET ZN B 147 1 HET BRD B 149 17 HETNAM ZN ZINC ION HETNAM BRD 1-BETA-RIBOFURANOSYL-1,3-DIAZEPINONE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 BRD 2(C10 H14 N2 O5) FORMUL 7 HOH *62(H2 O) HELIX 1 1 CYS A 14 LYS A 26 1 13 HELIX 2 2 GLN A 27 ALA A 29 5 3 HELIX 3 3 CYS A 59 GLY A 63 5 5 HELIX 4 4 CYS A 65 GLU A 77 1 13 HELIX 5 5 CYS A 99 GLU A 108 1 10 HELIX 6 6 VAL A 129 LEU A 133 1 5 HELIX 7 7 GLY A 138 LEU A 142 5 5 HELIX 8 8 CYS B 14 LYS B 26 1 13 HELIX 9 9 GLN B 27 ALA B 29 5 3 HELIX 10 10 CYS B 59 GLY B 63 5 5 HELIX 11 11 CYS B 65 SER B 76 1 12 HELIX 12 12 CYS B 99 PHE B 109 1 11 HELIX 13 13 VAL B 129 LEU B 133 1 5 HELIX 14 14 GLY B 138 LEU B 142 5 5 SHEET 1 A 5 ILE A 49 CYS A 53 0 SHEET 2 A 5 VAL A 38 LEU A 43 -1 N LEU A 42 O PHE A 50 SHEET 3 A 5 ALA A 84 SER A 89 -1 O ALA A 84 N LEU A 43 SHEET 4 A 5 PRO A 114 THR A 118 1 O TYR A 116 N ILE A 85 SHEET 5 A 5 TYR A 124 THR A 128 -1 O ILE A 125 N MET A 117 SHEET 1 B 5 ILE B 49 CYS B 53 0 SHEET 2 B 5 VAL B 38 THR B 44 -1 N LEU B 42 O PHE B 50 SHEET 3 B 5 PHE B 82 SER B 89 -1 O ALA B 88 N GLY B 39 SHEET 4 B 5 PRO B 114 THR B 118 1 O TYR B 116 N ILE B 85 SHEET 5 B 5 TYR B 124 THR B 128 -1 O MET B 127 N VAL B 115 LINK SG CYS A 65 ZN ZN A 147 1555 1555 2.55 LINK SG CYS A 99 ZN ZN A 147 1555 1555 2.46 LINK SG CYS A 102 ZN ZN A 147 1555 1555 2.39 LINK SG CYS B 65 ZN ZN B 147 1555 1555 2.49 LINK SG CYS B 99 ZN ZN B 147 1555 1555 2.30 LINK SG CYS B 102 ZN ZN B 147 1555 1555 2.41 LINK ZN ZN B 147 O HOH B 151 1555 1555 2.40 SITE 1 AC1 4 CYS A 65 GLU A 67 CYS A 99 CYS A 102 SITE 1 AC2 4 CYS B 65 CYS B 99 CYS B 102 HOH B 151 SITE 1 AC3 12 PHE A 36 VAL A 38 ASN A 54 GLU A 56 SITE 2 AC3 12 ILE A 64 CYS A 65 ALA A 66 GLU A 67 SITE 3 AC3 12 HOH A 159 ALA B 58 CYS B 59 TYR B 60 SITE 1 AC4 15 ALA A 58 CYS A 59 TYR A 60 PRO A 61 SITE 2 AC4 15 PHE B 36 VAL B 38 ASN B 54 GLU B 56 SITE 3 AC4 15 ILE B 64 CYS B 65 ALA B 66 GLU B 67 SITE 4 AC4 15 SER B 97 HOH B 151 HOH B 157 CRYST1 52.398 55.680 90.689 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019085 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017960 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011027 0.00000